The K Virus has already shown exceptional stability, minimizing uncontrollable risks, thanks to the study of Y-chromosome sealing gene mechanisms. This gene stability technology obtained from the study has been applied to the transformation of the K Virus.
A new therapy is not merely a single drug or biological agent, but an entire system, and the whole treatment system around the K Virus Therapy is gradually taking shape.
During the treatment, for example, the monitoring of K Virus titers, evaluation of treatment effects, and early warnings of side effects are of importance. This highlights the significance of clinical trials as all data needs to be obtained from them.
Yang Ping observed the latest reagent for a while, then carefully put it back in the fridge and took off his gloves.
